Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews
| Status: | Completed |
|---|---|
| Conditions: | Hematology |
| Therapuetic Areas: | Hematology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 10/25/2017 |
| Start Date: | March 31, 2017 |
| End Date: | June 6, 2017 |
The purpose of this study is to seek to understand the patient's perspective around deciding
to participate in a clinical trial for a Hemophilia therapy
to participate in a clinical trial for a Hemophilia therapy
Inclusion criteria for patients:
- Were screened and consented for the AskBio009-101study at any point in time
- Are able to speak and understand English
- Are between ages of 18 and 75
- Are physically able to participate in a one-hour phone interview
- Consented into this study independently of the AskBio009-101 study
Exclusion criteria for patients:
- N/A
Inclusion criteria for investigators and coordinators:
- Worked at a site as an investigator or study coordinator that consented a patient into
the
- AskBio009-101 trial at any point in time, including those that no longer work at a
AskBio009-101 site
- Are able to speak and understand English
- Are between ages of 18 and 75
- Are physically able to participate in a one-hour phone interview
Exclusion criteria for investigators and coordinators:
- Not directly involved in the consent process at the gene therapy site
We found this trial at
1
site
Click here to add this to my saved trials
